Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-015989
Filing Date
2025-06-06
Accepted
2025-06-06 16:20:49
Documents
1
Period of Report
2025-06-04

Document Format Files

Seq Description Document Type Size
1 form4-06062025_080642.html 4  
1 form4-06062025_080642.xml 4 4074
  Complete submission text file 0001415889-25-015989.txt   5520
Mailing Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133
Business Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133 415-978-1200
FIBROGEN INC (Issuer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AGIOS PHARMACEUTICALS, INC. 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Ho Maykin (Reporting) CIK: 0001646395 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36740 | Film No.: 251030982